Toronto Dominion Bank’s iShares Biotechnology ETF IBB Stock Holding History

Toronto Dominion Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-300	Closed	-$29K	–	1261
2016 Q3	$29K	Hold	300	–	–	﹤0.01%	1082
2016 Q2	$26K	Hold	300	–	–	﹤0.01%	1046
2016 Q1	$26K	Hold	300	–	–	﹤0.01%	1041
2015 Q4	$34K	Hold	300	–	–	﹤0.01%	938
2015 Q3	$30K	Hold	300	–	–	﹤0.01%	931
2015 Q2	$37K	Hold	300	–	–	﹤0.01%	964
2015 Q1	$34K	Hold	300	–	–	﹤0.01%	951
2014 Q4	$30K	Hold	300	–	–	﹤0.01%	929
2014 Q3	$0	Hold	300	–	–	﹤0.01%	955
2014 Q2	$26K	Hold	300	–	–	﹤0.01%	967
2014 Q1	$25K	Hold	300	–	–	﹤0.01%	961
2013 Q4	$23K	Hold	300	–	–	﹤0.01%	941
2013 Q3	$21K	Hold	300	–	–	﹤0.01%	685
2013 Q2	$17K	Buy	+300	New	+$17.3K	﹤0.01%	701

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Toronto Dominion Bank's IBB Position: Q4 2016 in Review

Toronto Dominion Bank sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 300 shares — an estimated $29K sold.

Toronto Dominion Bank first reported a position in IBB in Q2 2013 and held it in 14 quarters. The position peaked at $37K in Q2 2015. 523 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

Toronto Dominion Bank reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
Toronto Dominion Bank sold 300 iShares Biotechnology ETF shares in Q4 2016, an estimated $29K.
Toronto Dominion Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 14 quarters.
Toronto Dominion Bank's iShares Biotechnology ETF position peaked at $37K in Q2 2015.
523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Toronto Dominion Bank's 13F filing for Q4 2016, filed 6 Feb 2017.